Building on its autologous CD19 CAR-T cell therapy obe-cel, Autolus added a CD22 CAR to create AUTO1/22. The dual mechanism is intended to address a major cause of treatment failure. Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback